Wikipedia:WikiProject drugs
Tools
Actions
General
Print/export
Print/export
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Cocoapunk (talk | contribs) at 22:22, 7 November 2004 (→Categorization). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Title
WikiProject on Drugs (yes, yes, very funny)
Scope
This WikiProject aims primarily to organize and expand upon the existing drug-related articles on the Wikipedia, and to create new articles where necessary.
Parentage
No parent of this WikiProject has been defined.
Descendant WikiProjects
No descendant WikiProjects have been defined.
Similar WikiProjects
A similar WikiProject is WikiProject Clinical medicine.
Participants
- DryGrain
- Badanedwa
- Rkundalini
- Eequor
- Jfdwolff
- Daevatgl
- Techelf
- Foobar
- Aramgutang
- Jungboho 217.44.81.54 82.43.152.196
- Jaguar2k
- Mykhal
- Flying Hamster
- Cocoapunk Also under 69.136.240.91
- Cacycle
Structure
Organization based on drug classification.
Hierarchy definition
See Wikipedia:WikiProject_Drugs/categorization.
Goals
- Categorize all drug-related pages.
- Create msg boxes for Drug and each category (the drug msg-box will contain all categories, and specific categories' msg-boxes will contain links to actual articles of specific drugs, with possible sub-categorization).
- Remove inconsistencies in related articles and expand all stubs under the jurisdiction of the project.
- Create standard infoboxes for all drug pages.
- Find somebody who can make nice chemical structure diagrams for lots of drugs. See:
- Find suitable photographs for drug pages. See:
General strategy and discussion forum
Infobox
- {{subst:drugbox}}
Templates
General
- {{DrugsNotice}}
![]() | The WikiProject banner below should be moved to this redirect's talk page. If this is a demonstration of the template, please set the parameter |category=no to prevent this page being miscategorised. |
![]() | Pharmacology Redirect‑class | ||||||
|
Categorization
Nitrovasodilators | |
---|---|
Quinolone vasodilators | |
Others | |
|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
Benzimidazoles (*) | |
---|---|
Diarylmethanes |
|
Ethylenediamines | |
Tricyclics | |
Others |
|
For topical use |
5-HT1ARTooltip 5-HT1A receptor agonists | |
---|---|
GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators |
|
Hypnotics | |
Gabapentinoids (α2δ VDCC blockers) | |
Antidepressants |
|
Antipsychotics | |
Sympatholytics (Antiadrenergics) |
|
Others | |
|
β, non-selective | |
---|---|
β1-selective | |
β2-selective | |
α1- + β-selective | |
|
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
1,4-Benzodiazepines |
|
---|---|
1,5-Benzodiazepines | |
2,3-Benzodiazepines* | |
Triazolobenzodiazepines | |
Imidazobenzodiazepines | |
Oxazolobenzodiazepines | |
Thienodiazepines | |
Thienotriazolodiazepines | |
Thienobenzodiazepines* | |
Pyridodiazepines | |
Pyridotriazolodiazepines | |
Pyrazolodiazepines | |
Pyrrolodiazepines | |
Tetrahydroisoquinobenzodiazepines | |
Pyrrolobenzodiazepines* | |
Benzodiazepine prodrugs | |
* atypical activity profile (not GABAA receptor ligands) |
Calcium |
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Potassium |
| ||||||||||||||||||||||||
Sodium |
| ||||||||||||||||||||||||
Chloride |
| ||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||
GABAA |
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GABAB | |||||||||||||||||||||||||
H1 |
| ||||||||||||||||||||||||
α2-Adrenergic | |||||||||||||||||||||||||
5-HT2A |
| ||||||||||||||||||||||||
Melatonin | |||||||||||||||||||||||||
Orexin | |||||||||||||||||||||||||
α2δ VDCC | |||||||||||||||||||||||||
Others |
H2 antagonists ("-tidine") | |
---|---|
Prostaglandins (E)/ analogues ("-prost-") | |
Proton-pump inhibitors ("-prazole") | |
Potassium-competitive acid blockers ("-prazan") | |
Others | |
Combinations | |
|
GABAA |
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GABAB | |||||||||||||||||||||||||
H1 |
| ||||||||||||||||||||||||
α2-Adrenergic | |||||||||||||||||||||||||
5-HT2A |
| ||||||||||||||||||||||||
Melatonin | |||||||||||||||||||||||||
Orexin | |||||||||||||||||||||||||
α2δ VDCC | |||||||||||||||||||||||||
Others |
GI tract |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liver |
| ||||||||||||
Blood vessels |
| ||||||||||||
Combinations | |||||||||||||
Other | |||||||||||||
|
Adamantanes | |
---|---|
Adenosine antagonists | |
Alkylamines | |
Ampakines | |
Arylcyclohexylamines | |
Benzazepines | |
Cathinones |
|
Cholinergics |
|
Convulsants | |
Eugeroics | |
Oxazolines | |
Phenethylamines |
|
Phenylmorpholines | |
Piperazines | |
Piperidines |
|
Pyrrolidines | |
Racetams | |
Tropanes |
|
Tryptamines | |
Others |
|
Antimigraine preparations (N02C) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Analgesic/abortive |
| ||||||||||||||||
Prophylactic |
| ||||||||||||||||
|
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
Phenylalkyl- amines (other than cathinones) |
|
---|---|
Cyclized phenyl- alkylamines | |
Cathinones | |
Tryptamines | |
Chemical classes |
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
Phytocannabinoids (comparison) |
| ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endocannabinoids |
| ||||||||||||||||||||||||||||||||||||||||
Synthetic cannabinoid receptor agonists / neocannabinoids |
| ||||||||||||||||||||||||||||||||||||||||
Allosteric CBRTooltip Cannabinoid receptor ligands | |||||||||||||||||||||||||||||||||||||||||
Endocannabinoid enhancers (inactivation inhibitors) |
| ||||||||||||||||||||||||||||||||||||||||
Anticannabinoids (antagonists/inverse agonists/antibodies) |
| ||||||||||||||||||||||||||||||||||||||||
|